Cancer & SURVIVEiT News
Category Filter:
New FDA Approval for Locally Advanced or Metastatic Cholangiocarcinoma
Foundation Medicine Receives FDA Approval for FoundationOne®CDx as the Companion Diagnostic for Pemazyre™ (pemigatinib), the First FDA-Approved Targeted Therapy for Adults with Previously Treated Locally Advanced or Metastatic Cholangiocarcinoma April…